newsfilter
← Latest News
GlobeNewswire·

Grace Therapeutics Announces Second Quarter 2026 Financial Results, Provides Business Update

Announced U.S. Food and Drug Administration (FDA) Acceptance for Reviewof New Drug Application (NDA) for GTx-104 FDA Established April 23, 2026 as PDUFA Target Date for Review of Submission Seeking Approval for GTx-104